Chemed Corporation (CHE) Misses Q2 EPS by $1.12, Misses on Revenue; Offers FY25 EPS Guidance

Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.27, $1.12 worse than the analyst estimate of $5.39. Revenue for the quarter came in at $618.8 million versus the consensus estimate of $650.6 million.

GUIDANCE:

Chemed Corporation sees FY2025 EPS of $22.00-$22.30, versus the consensus of $23.29.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Reading (RDI) Tops Q2 EPS by 4c
• AI/ML Innovations plans $2M private placement on the CSE